Calidi Biotherapeutics, Inc.
CLDI- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855485
No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $89.3K in total; no superinvestor holds it.
Other share classesCLDWW
13F holders, Q2 2026
Institutional positions in Calidi Biotherapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −5 vs. Q1 2026
- Shares held
- 525.5K
- −1.48M (−73.8%) vs. Q1 2026
- Total value
- $89.3K
- −$389.4K (−81.3%) vs. Q1 2026
- New holders
- 4
- 7 more added
- Sold out
- 9
- 0 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLDI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $89.3K |
| Q1 2026 | 28 | $478.8K |
| Q4 2025 | 27 | $524.7K |
| Q3 2025 | 22 | $353.6K |
| Q2 2025 | 35 | $656.8K |
| Q1 2025 | 36 | $3.09M |
| Q4 2024 | 33 | $1.27M |
| Q3 2024 | 20 | $363.4K |
| Q2 2024 | 32 | $523.2K |
| Q1 2024 | 31 | $1.56M |
| Q4 2023 | 25 | $3.29M |
| Q3 2023 | 13 | $3.54M |
| Q2 2023 | 25 | $40.6M |
| Q1 2023 | 27 | $45.8M |
| Q4 2022 | 25 | $39.6M |
| Q3 2022 | 21 | $36.1M |
| Q2 2022 | 42 | $214.8M |
| Q1 2022 | 40 | $202.4M |
| Q4 2021 | 27 | $184.1M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Calidi Biotherapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 114,550 | $19.5K | 0.00% | +51,531+81.8% | Added |
| HighTower Advisors, LLC | 83,523 | $14.2K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 54,274 | $9.23K | 0.00% | +19,472+56.0% | Added |
| Independent Advisor Alliance | 45,000 | $7.65K | 0.00% | +45,000 | New |
| RS Crum Inc. | 43,239 | $7.35K | 0.00% | +2,983+7.4% | Added |
| SRS Capital Advisors, Inc. | 37,345 | $6.35K | 0.00% | 00.0% | Unchanged |
| Private Advisor Group, LLC | 30,000 | $5.10K | 0.00% | +30,000 | New |
| Vanguard Capital Management LLC | 25,509 | $4.34K | 0.00% | 00.0% | Unchanged |
| Belpointe Asset Management LLC | 19,921 | $3.39K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 17,758 | $3.02K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 13,244 | $2.25K | 0.00% | +3,777+39.9% | Added |
| RFG Advisory, LLC | 12,000 | $2.04K | 0.00% | +12,000 | New |
| Farther Finance Advisors, LLC | 10,000 | $1.70K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 7,882 | $1.34K | 0.00% | +7,882 | New |
| Citigroup Inc | 4,594 | $781 | 0.00% | +4,580+32,714.3% | Added |
| Advisor Group Holdings, Inc. | 2,650 | $450 | 0.00% | +544+25.8% | Added |
| Tower Research Capital LLC (TRC) | 1,396 | $237 | 0.00% | 00.0% | Unchanged |
| Finepoint Capital LP | 1,042 | $177 | 0.00% | 00.0% | Unchanged |
| Highbridge Capital Management LLC | 1,042 | $177 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 375 | $64 | 0.00% | +260+226.1% | Added |
| Tradewinds Capital Management, LLC | 101 | $18 | 0.00% | 00.0% | Unchanged |
| Reyes Financial Architecture, Inc. | 100 | $17 | 0.00% | 00.0% | Unchanged |
| Evermay Wealth Management LLC | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −879,000−100.0% | Sold out |
| Sabby Management, LLC | 0 | $0 | 0.00% | −434,903−100.0% | Sold out |
| Warberg Asset Management LLC | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −75,769−100.0% | Sold out |
| Vanguard Fiduciary Trust Co | 0 | $0 | 0.00% | −9,219−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −10,133−100.0% | Sold out |
| Apollo Management Holdings, L.P. | 0 | $0 | 0.00% | −1,042−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −255−100.0% | Sold out |
| CVA Family Office, LLC | 0 | $0 | 0.00% | −42−100.0% | Sold out |